72 filings
6-K
PYPD
Polypid Ltd
8 May 24
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
7:05am
6-K
PYPD
Polypid Ltd
30 Apr 24
Study Approximately Half Enrolled to the Planned Unblinded Interim Analysis
8:17am
6-K
PYPD
Polypid Ltd
14 Feb 24
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:16am
6-K
PYPD
Polypid Ltd
14 Feb 24
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
7:00am
6-K
PYPD
Polypid Ltd
5 Jan 24
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
9:28am
6-K
m6gzwn1d87 7nhctuf0
8 Nov 23
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
7:05am
6-K
mw8qv01xjee2ln
7 Nov 23
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors
7:05am
6-K
9621z 8rszxu3
11 Oct 23
Report of Foreign Private Issuer
7:12am
6-K
86adxmrr8djtr9ygyyk7
10 Oct 23
Report of Foreign Private Issuer
4:15pm
6-K
xivxtohf
10 Oct 23
Report of Foreign Private Issuer
4:05pm
6-K
p1a4zlnfvjezuu2npvmm
20 Sep 23
PolyPid Announces Reverse Share Split
9:21am
6-K
u3ek4m3lyj4fn
18 Sep 23
Report of Foreign Private Issuer
8:00am
6-K
pmcxkl08
1 Sep 23
Notice of EXTRAORDINARY General Meeting of shareholders
4:02pm
6-K
sxncxc2rlp6c
1 Sep 23
Notice of EXTRAORDINARY General Meeting of shareholders
4:00pm
6-K
35hz92p9c2
9 Aug 23
Report of Foreign Private Issuer
4:02pm
6-K
vc6r500vosaf
9 Aug 23
PolyPid Provides Corporate Update and Reports Second Quarter 2023 Financial Results
7:10am
6-K
ha00 u3ckj0
22 Jun 23
PolyPid Announces Recruitment of First Patient in Revised SHIELD II Phase 3 Trial Evaluating
7:11am
6-K
k0qc51hj7 42
5 Jun 23
PolyPid Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement and Transfer of its Listing to the Nasdaq Capital Market
4:06pm
6-K
ezzj cmp0r80t47
22 May 23
PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections
9:05am
6-K
bnxxuvad2ltzmq48fb
10 May 23
PolyPid Provides Corporate Update and Reports First Quarter 2023 Financial Results
7:05am